$GBCS
SELECTIS HEALTH, INC. Stock $gbcs

$gbcs Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000149315224014714 Filed on April 16, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue	$9.585M	$9.203M	$36.78M
YoY Change	7.35%	-14.79%	-9.4%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$9.939M	$11.77M	$44.08M
YoY Change	-1.3%	-0.21%	12.76%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$409.5K	$426.2K	$1.666M
YoY Change	-6.93%	-3.14%	-7.06%
% of Gross Profit
Operating Expenses	$10.35M	$12.20M	$45.74M
YoY Change	-1.55%	-0.27%	11.88%
Operating Profit	-$763.9K		-$8.960M
YoY Change	-51.75%		3026.76%
Interest Expense	-$585.7K	-$679.8K	$2.174M
YoY Change	-203.22%	-13.94%	-2.58%
% of Operating Profit
Other Income/Expense, Net	$1.558M	$40.09K	$4.989M
YoY Change	-401.0%	33.63%	-336.55%
Pretax Income	$794.3K	-$3.633M	-$3.971M
YoY Change	-137.83%	65.89%	65.46%
Income Tax
% Of Pretax Income
Net Earnings	$794.3K	-$3.641M	-$3.971M
YoY Change	-137.81%	65.48%	65.75%
Net Earnings / Revenue	8.29%	-39.56%	-10.8%
Basic Earnings Per Share	$0.26		-$1.31
Diluted Earnings Per Share	$0.26	-$1.19	-$1.31
COMMON SHARES
Basic Shares Outstanding	3.067M shares	3.055M shares	3.055M shares
Diluted Shares Outstanding	3.067M shares		3.055M shares

Balance Sheet

Concept	2024 Q2	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.221M	$1.485M	$1.485M
YoY Change	411.2%	4.55%	4.55%
Cash & Equivalents	$3.221M	$1.485M	$1.485M
Short-Term Investments
Other Short-Term Assets	$586.4K	$1.381M	$1.381M
YoY Change	-91.59%	115.71%	115.71%
Inventory
Prepaid Expenses
Receivables	$2.188M	$2.092M	$2.092M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$5.995M	$4.957M	$4.957M
YoY Change	-41.02%	-0.12%	-0.07%
LONG-TERM ASSETS
Property, Plant & Equipment	$28.86M	$33.82M	$33.82M
YoY Change	-16.65%	-4.62%	-4.6%
Goodwill	$1.077M	$1.077M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$802.7K	$820.1K	$820.1K
YoY Change	-25.67%	-17.99%	-17.99%
Total Long-Term Assets	$30.74M	$35.71M	$35.71M
YoY Change	-16.42%	-4.83%	-4.84%
TOTAL ASSETS
Total Short-Term Assets	$5.995M	$4.957M	$4.957M
Total Long-Term Assets	$30.74M	$35.71M	$35.71M
Total Assets	$36.73M	$40.67M	$40.67M
YoY Change	-21.75%	-4.28%	-4.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.722M	$6.045M	$6.045M
YoY Change	12.98%	66.08%	66.08%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$900.0K	$900.0K	$900.0K
YoY Change	500.0%	0.0%	0.0%
Long-Term Debt Due	$10.60M	$11.17M	$11.17M
YoY Change	-1.73%	386.33%	385.66%
Total Short-Term Liabilities	$18.26M	$18.15M	$18.15M
YoY Change	8.1%	164.97%	164.91%
LONG-TERM LIABILITIES
Long-Term Debt	$21.60M	$25.18M	$25.18M
YoY Change	-17.33%	-26.81%	-26.81%
Other Long-Term Liabilities	$85.15K	$312.8K	$312.8K
YoY Change	-71.62%	7.84%	7.84%
Total Long-Term Liabilities	$21.60M	$25.18M	$25.49M
YoY Change	-17.33%	-26.81%	-26.52%
TOTAL LIABILITIES
Total Short-Term Liabilities	$18.26M	$18.15M	$18.15M
Total Long-Term Liabilities	$21.60M	$25.18M	$25.49M
Total Liabilities	$39.95M	$43.64M	$43.64M
YoY Change	-9.36%	5.05%	5.04%
SHAREHOLDERS EQUITY
Retained Earnings	-$18.00M	-$17.75M
YoY Change	52.1%	29.11%
Common Stock	$153.4K	$153.4K
YoY Change	0.41%	0.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$3.219M	-$2.964M	-$2.964M
YoY Change
Total Liabilities & Shareholders Equity	$36.73M	$40.67M	$40.67M
YoY Change	-21.75%	-4.28%	-4.28%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$794.3K	-$3.641M	-$3.971M
YoY Change	-137.81%	65.48%	65.75%
Depreciation, Depletion And Amortization	$409.5K	$426.2K	$1.666M
YoY Change	-6.93%	-3.14%	-7.06%
Cash From Operating Activities	-$422.9K	-$1.853M	$500.0K
YoY Change	-522.92%	-645.1%	-266.67%
INVESTING ACTIVITIES
Capital Expenditures	-$89.77K	-$190.00	$29.81K
YoY Change		-99.83%	-86.6%
Acquisitions
YoY Change
Other Investing Activities	$2.485M
YoY Change
Cash From Investing Activities	$2.575M	$190.00	-$29.81K
YoY Change		-99.83%	-86.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-161.2K	1.091M	-$618.7K
YoY Change	-72.68%	-236.41%	-66.54%
NET CHANGE
Cash From Operating Activities	-422.9K	-1.853M	$500.0K
Cash From Investing Activities	2.575M	190.0	-$29.81K
Cash From Financing Activities	-161.2K	1.091M	-$618.7K
Net Change In Cash	1.990M	-761.9K	-$111.9K
YoY Change	-506.22%	117.68%	-95.29%
FREE CASH FLOW
Cash From Operating Activities	-$422.9K	-$1.853M	$500.0K
Capital Expenditures	-$89.77K	-$190.00	$29.81K
Free Cash Flow	-$333.1K	-$1.853M	$470.2K
YoY Change	-433.15%	-511.81%	-190.01%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000727346
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2022	GBCS	Income From Employee Retention Credits IncomeFromEmployeeRetentionCredits		usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2023	GBCS	Other Income From Partial Settlement Of Debt OtherIncomeFromPartialSettlementOfDebt		usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2022	GBCS	Issuance Of Common Stock For Cashless Exercise Of Warrants IssuanceOfCommonStockForCashlessExerciseOfWarrants		usd
CY2023	GBCS	Issuance Of Common Stock For Debt IssuanceOfCommonStockForDebt		usd
CY2023	GBCS	Effect Of Dilutive Securities EffectOfDilutiveSecurities		shares
CY2022	GBCS	Effect Of Dilutive Securities EffectOfDilutiveSecurities		shares
CY2023	GBCS	Exercise Of Stock Options ExerciseOfStockOptions		shares
CY2022	GBCS	Exercise Of Stock Options ExerciseOfStockOptions		shares
CY2023	GBCS	Exercise Of Warrants ExerciseOfWarrants		shares
CY2022	GBCS	Exercise Of Warrants ExerciseOfWarrants		shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2022Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome		usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts		usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits		usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits		usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions		usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits		usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod		usd
CY2023	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	11275080	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3067059	shares
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	688
CY2023	dei	Auditor Name AuditorName	Marcum LLP
CY2023	dei	Auditor Location AuditorLocation	Costa Mesa, CA
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1484599	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1420200	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2091536	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2904741	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1380570	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	637680	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	4956705	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	4962621	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	820124	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	996400	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	33817718	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	35454113	usd
CY2023Q4	us-gaap	Goodwill Goodwill	1076908	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1076908	usd
CY2023Q4	us-gaap	Assets Assets	40671455	usd
CY2022Q4	us-gaap	Assets Assets	42490042	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	6045365	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3644001	usd
CY2023Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	30600	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	168458	usd
CY2022Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	7500	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	524704	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	257222	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	11170100	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2296830	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	18146065	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6848331	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	30663	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	0	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	25176435	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	34397488	usd
CY2023Q4	us-gaap	Security Deposit Liability SecurityDepositLiability	312750	usd
CY2022Q4	us-gaap	Security Deposit Liability SecurityDepositLiability	291388	usd
CY2023Q4	us-gaap	Liabilities Liabilities	43635250	usd
CY2022Q4	us-gaap	Liabilities Liabilities	41537207	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3067059	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3067059	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3067059	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3067059	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	153352	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	152728	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	13852028	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	13768300	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17745175	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13744193	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2963795	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	952835	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	40671455	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	42490042	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	36783047	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	40599517	usd
CY2023	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	31375921	usd
CY2022	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	29859250	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1666200	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1792840	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	45743466	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	40886089	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-8960419	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-286572	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-46466	usd
CY2023	us-gaap	Interest Expense InterestExpense	2173763	usd
CY2022	us-gaap	Interest Expense InterestExpense	2231233	usd
CY2023	GBCS	Income From Employee Retention Credits IncomeFromEmployeeRetentionCredits	6866759	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	296442	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4989437	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2109241	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-3970982	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-2395813	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-3970982	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2395813	usd
CY2023	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	30000	usd
CY2022	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	30000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4000982	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2425813	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.31
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.79
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.31
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.79
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3054587	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3054126	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3054587	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3054126	shares
CY2023	us-gaap	Profit Loss ProfitLoss	-3970982	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-2395813	usd
CY2022	GBCS	Other Income From Partial Settlement Of Debt OtherIncomeFromPartialSettlementOfDebt	40436	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1666200	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1792840	usd
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	347783	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	315983	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2733157	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1364354	usd
CY2023	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	624	usd
CY2023	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	662000	usd
CY2022	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	762376	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2000842	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1007041	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2401364	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1648547	usd
CY2023	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	21362	usd
CY2022	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	61806	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	536666	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-305148	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	29805	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	222361	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-29805	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-222361	usd
CY2023	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	695566	usd
CY2022	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	1865458	usd
CY2023	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	6900	usd
CY2022	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	30000	usd
CY2023	GBCS	Proceeds From Debt Discount Warrants Related Parties ProceedsFromDebtDiscountWarrantsRelatedParties	83728	usd
CY2022	GBCS	Proceeds From Debt Discount Warrants Related Parties ProceedsFromDebtDiscountWarrantsRelatedParties	46466	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-618738	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1848992	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-111877	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2376501	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2416600	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4793101	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2304723	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2416600	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	1782489	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	1570520	usd
CY2023Q4	us-gaap	Cash Cash	1484599	usd
CY2022Q4	us-gaap	Cash Cash	1420200	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	820124	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	996400	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2304723	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2416600	usd
CY2023	GBCS	Dividends Declared On Series D Preferred Stock DividendsDeclaredOnSeriesDPreferredStock	30000	usd
CY2022	GBCS	Dividends Declared On Series D Preferred Stock DividendsDeclaredOnSeriesDPreferredStock	30000	usd
CY2023	GBCS	Issuance Of Common Stock For Cashless Exercise Of Warrants IssuanceOfCommonStockForCashlessExerciseOfWarrants	84352	usd
CY2022	GBCS	Issuance Of Common Stock For Debt IssuanceOfCommonStockForDebt	230000	usd
CY2023	GBCS	Financing Of Insurance Premiums FinancingOfInsurancePremiums	1021676	usd
CY2022	GBCS	Financing Of Insurance Premiums FinancingOfInsurancePremiums	581393	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84D_eus-gaap--UseOfEstimates_z0U7zvMuYzO2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zM01hL9Tc8S2">Use of Estimates and Assumptions</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP” or “GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates included herein relate to the recoverability of assets, the purchase price allocation for properties acquired, and the fair value of certain assets and liabilities. Actual results may differ from estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	500000	usd
CY2023Q4	GBCS	Working Capital Deficit WorkingCapitalDeficit	-13200000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	11170100	usd
CY2023Q4	us-gaap	Escrow Deposit EscrowDeposit	820124	usd
CY2022Q4	us-gaap	Escrow Deposit EscrowDeposit	996400	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_zS9HFsZRqkH6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zmuae4x5bAk5">Concentration of Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains deposits in financial institutions that at times exceed the insured amount of $<span id="xdx_900_eus-gaap--CashFDICInsuredAmount_iI_c20231231_zZaM2WhGm224" title="Cash, FDIC insured amount">250,000</span> provided by the U.S. Federal Deposit Insurance Corporation (FDIC). The Company went to an Insured Cash Sweep service (ICS) in 2021. ICS funds are eligible for multi-million-dollar FDIC insurance that’s backed by the full faith and credit of the United States government. Daily cash is swept and deposited to as many banks as needed that are FDIC insured. This insures no amounts exceed a $<span id="xdx_902_eus-gaap--CashFDICInsuredAmount_iI_c20231231_zl3XVu0Frxi3" title="Cash, FDIC insured amount">250,000</span> balance which is fully insured by the FDIC. The funds can be tracked by its primary financial institution. New funds can be deposited and withdrawn from that single relationship. The Company believes the financial institutions it uses are credit worthy and stable. The Company does not believe that it is exposed to any significant credit risk in cash and cash equivalents or restricted cash.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	347783	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	315983	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1874068000000	usd
CY2023	us-gaap	Other Expenses OtherExpenses	1475205000000	usd
CY2023Q1	GBCS	Employee Retention Credits Receivable EmployeeRetentionCreditsReceivable	6866759	usd
CY2023Q4	GBCS	Sharebased Arrangements Liability Of Incurred SharebasedArrangementsLiabilityOfIncurred	625	usd
CY2022Q4	GBCS	Sharebased Arrangements Liability Of Incurred SharebasedArrangementsLiabilityOfIncurred	0	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-3970982	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2395813	usd
CY2023	GBCS	Preferred Stock Dividends And Other Adjustments Basic PreferredStockDividendsAndOtherAdjustmentsBasic	30000	usd
CY2022	GBCS	Preferred Stock Dividends And Other Adjustments Basic PreferredStockDividendsAndOtherAdjustmentsBasic	30000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4000982	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2425813	usd
CY2023	GBCS	Net Income Loss Attributable To Diluted Gross NetIncomeLossAttributableToDilutedGross	-3970982	usd
CY2022	GBCS	Net Income Loss Attributable To Diluted Gross NetIncomeLossAttributableToDilutedGross	-2395813	usd
CY2023	GBCS	Preferred Stock Dividends And Other Adjustments Diluted PreferredStockDividendsAndOtherAdjustmentsDiluted	30000	usd
CY2022	GBCS	Preferred Stock Dividends And Other Adjustments Diluted PreferredStockDividendsAndOtherAdjustmentsDiluted	30000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-4000982	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-2425813	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3054587	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3054126	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3054587	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3054126	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3054587	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3054126	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.31
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.79
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.31
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.79
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	49256168	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	49226364	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	13878450	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	12212251	usd
CY2023Q4	GBCS	Impairment Property Plant And Equipment ImpairmentPropertyPlantAndEquipment	1560000	usd
CY2022Q4	GBCS	Impairment Property Plant And Equipment ImpairmentPropertyPlantAndEquipment	1560000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	33817718	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	35454113	usd
CY2023	us-gaap	Depreciation Depreciation	1666200	usd
CY2022	us-gaap	Depreciation Depreciation	1792840	usd
CY2023	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	29805	usd
CY2022	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	222361	usd
CY2023Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	37801902	usd
CY2022Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	38405315	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	555367	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	810997	usd
CY2023Q4	GBCS	Debt Longterm And Shortterm Combined Net Amount DebtLongtermAndShorttermCombinedNetAmount	37246536	usd
CY2022Q4	GBCS	Debt Longterm And Shortterm Combined Net Amount DebtLongtermAndShorttermCombinedNetAmount	37594318	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	11170100	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2296830	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	25176435	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	34397488	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	84352	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	30000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.00
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	30000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.00
CY2023	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	695566	usd
CY2022	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	1865458	usd
CY2023	us-gaap	Adjustment For Amortization AdjustmentForAmortization	347783	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	315983	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	12625468	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	7579734	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	601466	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	1546429	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	15448807	usd
CY2023Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	37801903	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	931446	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023	us-gaap	Dividends Preferred Stock DividendsPreferredStock	30000	usd
CY2022	us-gaap	Dividends Preferred Stock DividendsPreferredStock	30000	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	30000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.00
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	30000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	30000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	30000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.00
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	643401	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	651954	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	660665	usd
CY2023Q4	GBCS	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	55116	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2011136	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	-0.22	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	-0.89	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	-0.33	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.04	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.10	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.04	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.42	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.68	pure
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2781168	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2296982	usd
CY2023Q4	GBCS	Impairment Loss On Long Term Assets Impairment Loss On Long Term Assets ImpairmentLossOnLongTermAssetsImpairmentLossOnLongTermAssets	390295	usd
CY2022Q4	GBCS	Impairment Loss On Long Term Assets Impairment Loss On Long Term Assets ImpairmentLossOnLongTermAssetsImpairmentLossOnLongTermAssets	393026	usd
CY2023Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	485044	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	545768	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4202275	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2690008	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1391332	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1502934	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	9478	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	8807	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1400810	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1511741	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2801465	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1178267	usd
CY2023	GBCS	Operating Loss Carryforwards Expiration Year OperatingLossCarryforwardsExpirationYear	2037
CY2023	us-gaap	Operating Loss Carryforwards Limitations On Use OperatingLossCarryforwardsLimitationsOnUse	subject to the 80% taxable income limitation
CY2021	GBCS	Bad Debt Allowance BadDebtAllowance	1901203	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	454439	usd
CY2023	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	454439	usd
CY2022	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	-478988	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	24549	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	454439	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2021Q4	us-gaap	Goodwill Goodwill	1076908	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1076908	usd
CY2023Q4	us-gaap	Goodwill Goodwill	1076908	usd

Files In Submission

Name	View Source	Status
0001493152-24-014714-index-headers.html	Edgar Link	pending
0001493152-24-014714-index.html	Edgar Link	pending
0001493152-24-014714.txt	Edgar Link	pending
0001493152-24-014714-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
gbcs-20231231.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
gbcs-20231231_cal.xml	Edgar Link	unprocessable
gbcs-20231231_def.xml	Edgar Link	unprocessable
gbcs-20231231_lab.xml	Edgar Link	unprocessable
gbcs-20231231_pre.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GBCS
SELECTIS HEALTH, INC. Stock $gbcs

2024 Q2 Form 10-K Financial Statement

#000149315224014714 Filed on April 16, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GBCS SELECTIS HEALTH, INC. Stock $gbcs

2024 Q2 Form 10-K Financial Statement

#000149315224014714 Filed on April 16, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GBCS
SELECTIS HEALTH, INC. Stock $gbcs